Acorah Software Products - Accounts Production 16.3.350 false true false true No description of principal activity 9 December 2023 31 December 2024 31 December 2024 15338183 Mr V Bhargava iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15338183 2023-12-08 15338183 2024-12-31 15338183 2023-12-09 2024-12-31 15338183 frs-core:CurrentFinancialInstruments 2024-12-31 15338183 frs-bus:PrivateLimitedCompanyLtd 2023-12-09 2024-12-31 15338183 frs-bus:FilletedAccounts 2023-12-09 2024-12-31 15338183 frs-bus:Micro-entities 2023-12-09 2024-12-31 15338183 frs-bus:AuditExempt-NoAccountantsReport 2023-12-09 2024-12-31 15338183 frs-bus:Director1 2023-12-09 2024-12-31
Registered number: 15338183
Pharmika Ltd
Unaudited Financial Statements
For the Period 9 December 2023 to 31 December 2024
Balance Sheet
Registered number: 15338183
31 December 2024
£
Fixed assets 11,295
Current assets 563
Creditors: Amounts Falling Due Within One Year (6,359 )
NET CURRENT LIABILITIES (5,796 )
TOTAL ASSETS LESS CURRENT LIABILITIES 5,499
NET ASSETS 5,499
CAPITAL AND RESERVES 5,499

Notes

1. General Information
Pharmika Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15338183 . The registered office is 7 Camborne Avenue, Aylesbury, HP21 7UZ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
Page 0
Page 1
For the period ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr V Bhargava
Director
2nd September 2025